Drug Discovery Services Market Size, Trends, Analysis, and Outlook By Process (Target Selection, Target Validation, Hit-to-Lead identification, Lead Optimization, Candidate Validation), By Type (Chemistry Services, Biology Services), By Drug (Small-molecule drugs, Biologics), By Therapeutic Area (Oncology, Infectious diseases, Neurological diseases, Immunological diseases, Endocrine and metabolic diseases, Respiratory diseases, Cardiovascular diseases, Others), By End-User (Pharmaceutical & Biotechnology companies, Academic Institutes, Others), by Country, Segment, and Companies, 2024-2032
The global Drug Discovery Services market size is poised to register 13.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Drug Discovery Services market across By Process (Target Selection, Target Validation, Hit-to-Lead identification, Lead Optimization, Candidate Validation), By Type (Chemistry Services, Biology Services), By Drug (Small-molecule drugs, Biologics), By Therapeutic Area (Oncology, Infectious diseases, Neurological diseases, Immunological diseases, Endocrine and metabolic diseases, Respiratory diseases, Cardiovascular diseases, Others), By End-User (Pharmaceutical & Biotechnology companies, Academic Institutes, Others)
The drug discovery services market is characterized by the increasing outsourcing of drug discovery and development activities, advancements in high-throughput screening (HTS) and computational modeling techniques, and the growing need for novel therapeutics targeting complex diseases. By 2030, the market is poised to witness steady growth, driven by innovations in target identification, lead optimization, and preclinical testing services. Further, expanding applications in phenotypic screening, virtual screening, and artificial intelligence (AI)-driven drug discovery are expected to drive market expansion, enabling pharmaceutical companies, biotech startups, and academic research centers to accelerate drug discovery timelines, reduce R&D costs, and increase drug candidate success rates through drug discovery services that offer expertise, infrastructure, and technology platforms for early-stage drug discovery and validation in therapeutic areas such as oncology, neurology, and rare diseases.
Drug Discovery Services Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Drug Discovery Services market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Drug Discovery Services survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Drug Discovery Services industry.
Key market trends defining the global Drug Discovery Services demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Drug Discovery Services Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Drug Discovery Services industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Drug Discovery Services companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Drug Discovery Services industry
Leading Drug Discovery Services companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Drug Discovery Services companies.
Drug Discovery Services Market Study- Strategic Analysis Review
The Drug Discovery Services market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Drug Discovery Services industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Drug Discovery Services Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Drug Discovery Services Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Drug Discovery Services market segments. Similarly, Strong market demand is encouraging Canadian Drug Discovery Services companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Drug Discovery Services market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Drug Discovery Services Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Drug Discovery Services industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Drug Discovery Services market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Drug Discovery Services Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Drug Discovery Services in Asia Pacific. In particular, China, India, and South East Asian Drug Discovery Services markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Drug Discovery Services Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Drug Discovery Services Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Drug Discovery Services market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Drug Discovery Services.
Drug Discovery Services Market Company Profiles
The global Drug Discovery Services market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Aurigene Discovery Technologies, Charles River Laboratories International Inc, Curia Global Inc, Eurofins Scientific SE, Evotec SE, Frontage Holdings Corp, GenScript Biotech Corp, Jubilant Pharmova Ltd, Laboratory Corp of America Holdings, Oncodesign Services, Pharmaron Beijing Co. Ltd, Piramal Enterprises Ltd, Shanghai Medicilon Inc, Sygnature Discovery Ltd, Syngene International Ltd, Thermo Fisher Scientific Inc, WuXi AppTec.
Recent Drug Discovery Services Market Developments
The global Drug Discovery Services market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Drug Discovery Services Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Process
Target Selection
Target Validation
Hit-to-Lead identification
Lead Optimization
Candidate Validation
By Type
Chemistry Services
Biology Services
By Drug
Small-molecule drugs
Biologics
By Therapeutic Area
Oncology
Infectious diseases
Neurological diseases
Immunological diseases
Endocrine and metabolic diseases
Respiratory diseases
Cardiovascular diseases
Others
By End-User
Pharmaceutical & Biotechnology companies
Academic Institutes
Others
Geographical Segmentation:
Aurigene Discovery Technologies
Charles River Laboratories International Inc
Curia Global Inc
Eurofins Scientific SE
Evotec SE
Frontage Holdings Corp
GenScript Biotech Corp
Jubilant Pharmova Ltd
Laboratory Corp of America Holdings
Oncodesign Services
Pharmaron Beijing Co. Ltd
Piramal Enterprises Ltd
Shanghai Medicilon Inc
Sygnature Discovery Ltd
Syngene International Ltd
Thermo Fisher Scientific Inc
WuXi AppTec
Formats Available: Excel, PDF, and PPT
The drug discovery services market is characterized by the increasing outsourcing of drug discovery and development activities, advancements in high-throughput screening (HTS) and computational modeling techniques, and the growing need for novel therapeutics targeting complex diseases. By 2030, the market is poised to witness steady growth, driven by innovations in target identification, lead optimization, and preclinical testing services. Further, expanding applications in phenotypic screening, virtual screening, and artificial intelligence (AI)-driven drug discovery are expected to drive market expansion, enabling pharmaceutical companies, biotech startups, and academic research centers to accelerate drug discovery timelines, reduce R&D costs, and increase drug candidate success rates through drug discovery services that offer expertise, infrastructure, and technology platforms for early-stage drug discovery and validation in therapeutic areas such as oncology, neurology, and rare diseases.
Drug Discovery Services Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Drug Discovery Services market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Drug Discovery Services survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Drug Discovery Services industry.
Key market trends defining the global Drug Discovery Services demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Drug Discovery Services Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Drug Discovery Services industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Drug Discovery Services companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Drug Discovery Services industry
Leading Drug Discovery Services companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Drug Discovery Services companies.
Drug Discovery Services Market Study- Strategic Analysis Review
The Drug Discovery Services market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Drug Discovery Services industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Drug Discovery Services Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Drug Discovery Services Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Drug Discovery Services market segments. Similarly, Strong market demand is encouraging Canadian Drug Discovery Services companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Drug Discovery Services market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Drug Discovery Services Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Drug Discovery Services industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Drug Discovery Services market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Drug Discovery Services Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Drug Discovery Services in Asia Pacific. In particular, China, India, and South East Asian Drug Discovery Services markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Drug Discovery Services Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Drug Discovery Services Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Drug Discovery Services market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Drug Discovery Services.
Drug Discovery Services Market Company Profiles
The global Drug Discovery Services market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Aurigene Discovery Technologies, Charles River Laboratories International Inc, Curia Global Inc, Eurofins Scientific SE, Evotec SE, Frontage Holdings Corp, GenScript Biotech Corp, Jubilant Pharmova Ltd, Laboratory Corp of America Holdings, Oncodesign Services, Pharmaron Beijing Co. Ltd, Piramal Enterprises Ltd, Shanghai Medicilon Inc, Sygnature Discovery Ltd, Syngene International Ltd, Thermo Fisher Scientific Inc, WuXi AppTec.
Recent Drug Discovery Services Market Developments
The global Drug Discovery Services market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Drug Discovery Services Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Process
Target Selection
Target Validation
Hit-to-Lead identification
Lead Optimization
Candidate Validation
By Type
Chemistry Services
Biology Services
By Drug
Small-molecule drugs
Biologics
By Therapeutic Area
Oncology
Infectious diseases
Neurological diseases
Immunological diseases
Endocrine and metabolic diseases
Respiratory diseases
Cardiovascular diseases
Others
By End-User
Pharmaceutical & Biotechnology companies
Academic Institutes
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Aurigene Discovery Technologies
Charles River Laboratories International Inc
Curia Global Inc
Eurofins Scientific SE
Evotec SE
Frontage Holdings Corp
GenScript Biotech Corp
Jubilant Pharmova Ltd
Laboratory Corp of America Holdings
Oncodesign Services
Pharmaron Beijing Co. Ltd
Piramal Enterprises Ltd
Shanghai Medicilon Inc
Sygnature Discovery Ltd
Syngene International Ltd
Thermo Fisher Scientific Inc
WuXi AppTec
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Drug Discovery Services Market Overview and Key Findings, 2024
1.2 Drug Discovery Services Market Size and Growth Outlook, 2021- 2030
1.3 Drug Discovery Services Market Growth Opportunities to 2030
1.4 Key Drug Discovery Services Market Trends and Challenges
1.4.1 Drug Discovery Services Market Drivers and Trends
1.4.2 Drug Discovery Services Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Drug Discovery Services Companies
2. DRUG DISCOVERY SERVICES MARKET SIZE OUTLOOK TO 2030
2.1 Drug Discovery Services Market Size Outlook, USD Million, 2021- 2030
2.2 Drug Discovery Services Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. DRUG DISCOVERY SERVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. DRUG DISCOVERY SERVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Process
Target Selection
Target Validation
Hit-to-Lead identification
Lead Optimization
Candidate Validation
By Type
Chemistry Services
Biology Services
By Drug
Small-molecule drugs
Biologics
By Therapeutic Area
Oncology
Infectious diseases
Neurological diseases
Immunological diseases
Endocrine and metabolic diseases
Respiratory diseases
Cardiovascular diseases
Others
By End-User
Pharmaceutical & Biotechnology companies
Academic Institutes
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Drug Discovery Services Market, 2025
5.2 Asia Pacific Drug Discovery Services Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Drug Discovery Services Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Drug Discovery Services Market, 2025
5.5 Europe Drug Discovery Services Market Size Outlook by Type, 2021- 2030
5.6 Europe Drug Discovery Services Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Drug Discovery Services Market, 2025
5.8 North America Drug Discovery Services Market Size Outlook by Type, 2021- 2030
5.9 North America Drug Discovery Services Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Drug Discovery Services Market, 2025
5.11 South America Pacific Drug Discovery Services Market Size Outlook by Type, 2021- 2030
5.12 South America Drug Discovery Services Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Drug Discovery Services Market, 2025
5.14 Middle East Africa Drug Discovery Services Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Drug Discovery Services Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Drug Discovery Services Market Size Outlook and Revenue Growth Forecasts
6.2 US Drug Discovery Services Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Drug Discovery Services Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Drug Discovery Services Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Drug Discovery Services Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Drug Discovery Services Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Drug Discovery Services Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Drug Discovery Services Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Drug Discovery Services Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Drug Discovery Services Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Drug Discovery Services Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Drug Discovery Services Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Drug Discovery Services Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Drug Discovery Services Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Drug Discovery Services Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Drug Discovery Services Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Drug Discovery Services Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Drug Discovery Services Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Drug Discovery Services Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Drug Discovery Services Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Drug Discovery Services Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Drug Discovery Services Industry Drivers and Opportunities
7. DRUG DISCOVERY SERVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. DRUG DISCOVERY SERVICES COMPANY PROFILES
8.1 Profiles of Leading Drug Discovery Services Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Aurigene Discovery Technologies
Charles River Laboratories International Inc
Curia Global Inc
Eurofins Scientific SE
Evotec SE
Frontage Holdings Corp
GenScript Biotech Corp
Jubilant Pharmova Ltd
Laboratory Corp of America Holdings
Oncodesign Services
Pharmaron Beijing Co. Ltd
Piramal Enterprises Ltd
Shanghai Medicilon Inc
Sygnature Discovery Ltd
Syngene International Ltd
Thermo Fisher Scientific Inc
WuXi AppTec.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Drug Discovery Services Market Overview and Key Findings, 2024
1.2 Drug Discovery Services Market Size and Growth Outlook, 2021- 2030
1.3 Drug Discovery Services Market Growth Opportunities to 2030
1.4 Key Drug Discovery Services Market Trends and Challenges
1.4.1 Drug Discovery Services Market Drivers and Trends
1.4.2 Drug Discovery Services Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Drug Discovery Services Companies
2. DRUG DISCOVERY SERVICES MARKET SIZE OUTLOOK TO 2030
2.1 Drug Discovery Services Market Size Outlook, USD Million, 2021- 2030
2.2 Drug Discovery Services Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. DRUG DISCOVERY SERVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. DRUG DISCOVERY SERVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Process
Target Selection
Target Validation
Hit-to-Lead identification
Lead Optimization
Candidate Validation
By Type
Chemistry Services
Biology Services
By Drug
Small-molecule drugs
Biologics
By Therapeutic Area
Oncology
Infectious diseases
Neurological diseases
Immunological diseases
Endocrine and metabolic diseases
Respiratory diseases
Cardiovascular diseases
Others
By End-User
Pharmaceutical & Biotechnology companies
Academic Institutes
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Drug Discovery Services Market, 2025
5.2 Asia Pacific Drug Discovery Services Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Drug Discovery Services Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Drug Discovery Services Market, 2025
5.5 Europe Drug Discovery Services Market Size Outlook by Type, 2021- 2030
5.6 Europe Drug Discovery Services Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Drug Discovery Services Market, 2025
5.8 North America Drug Discovery Services Market Size Outlook by Type, 2021- 2030
5.9 North America Drug Discovery Services Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Drug Discovery Services Market, 2025
5.11 South America Pacific Drug Discovery Services Market Size Outlook by Type, 2021- 2030
5.12 South America Drug Discovery Services Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Drug Discovery Services Market, 2025
5.14 Middle East Africa Drug Discovery Services Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Drug Discovery Services Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Drug Discovery Services Market Size Outlook and Revenue Growth Forecasts
6.2 US Drug Discovery Services Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Drug Discovery Services Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Drug Discovery Services Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Drug Discovery Services Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Drug Discovery Services Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Drug Discovery Services Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Drug Discovery Services Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Drug Discovery Services Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Drug Discovery Services Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Drug Discovery Services Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Drug Discovery Services Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Drug Discovery Services Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Drug Discovery Services Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Drug Discovery Services Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Drug Discovery Services Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Drug Discovery Services Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Drug Discovery Services Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Drug Discovery Services Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Drug Discovery Services Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Drug Discovery Services Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Drug Discovery Services Industry Drivers and Opportunities
7. DRUG DISCOVERY SERVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. DRUG DISCOVERY SERVICES COMPANY PROFILES
8.1 Profiles of Leading Drug Discovery Services Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Aurigene Discovery Technologies
Charles River Laboratories International Inc
Curia Global Inc
Eurofins Scientific SE
Evotec SE
Frontage Holdings Corp
GenScript Biotech Corp
Jubilant Pharmova Ltd
Laboratory Corp of America Holdings
Oncodesign Services
Pharmaron Beijing Co. Ltd
Piramal Enterprises Ltd
Shanghai Medicilon Inc
Sygnature Discovery Ltd
Syngene International Ltd
Thermo Fisher Scientific Inc
WuXi AppTec.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
